Quick Takeaways
- VANGUARD GROUP INC filed SCHEDULE 13G/A for Bio-Rad Laboratories Inc Common Stock (BIO).
- Disclosed ownership: 8.4%.
- Date of event: 30 Sep 2024.
VANGUARD GROUP INC - 30 Sep 2024 SCHEDULE 13G/A Report for Bio-Rad Laboratories Inc Common Stock (BIO)
- Filing Manager
- VANGUARD GROUP INC
- Reporting Manager
- The Vanguard Group - 23-1945930
- Symbol
- BIO
- Shares outstanding
- 22,791,398 shares
- Disclosed Ownership
- 1,907,640 shares
- Ownership
- 8.4%
- Form type
- SCHEDULE 13G/A
- Filing time
- 20 Dec 2024, 16:50:29 UTC
- Date of event
- 30 Sep 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"VANGUARD GROUP INC disclosed 8.4% ownership in Bio-Rad Laboratories Inc Common Stock (BIO) on 30 Sep 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 20 Dec 2024, 16:50.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| The Vanguard Group - 23-1945930 | 8.4% | 1,907,640 | 0 | 10,818 | Ashley Grim | Head of Global Fund Administration |